Tenax Therapeutics, Inc.

TENX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 21, 2026 PRIMARY DOCUMENT
SCHEDULE 13G/A Oct 15, 2026
SCHEDULE 13G/A Oct 13, 2026
SCHEDULE 13G/A Oct 9, 2026
8-K Oct 8, 2026 8-K
4 Sep 17, 2026 4
4 Sep 15, 2026 PRIMARY DOCUMENT
4 Sep 15, 2026 4
SCHEDULE 13G/A Sep 11, 2026
8-K Sep 9, 2026 8-K
4 Sep 8, 2026 PRIMARY DOCUMENT
SCHEDULE 13G Sep 8, 2026
SCHEDULE 13G/A Sep 8, 2026
4 Sep 2, 2026 PRIMARY DOCUMENT
SCHEDULE 13G Aug 27, 2026
SCHEDULE 13G Aug 27, 2026
4 Aug 24, 2026 PRIMARY DOCUMENT
3 Aug 24, 2026 PRIMARY DOCUMENT
SCHEDULE 13G Aug 18, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 14, 2026
← Newer Page 1 of 39 · 973 filings Older →